Real-time continuous glucose monitoring improves glycaemic variability and neonatal outcomes in pregnant women with type 1 diabetes

Commentary on: Feig DS, Donovan LE, Corcoy R, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet 2017;390(10110):2347-59. Risk of adverse obstetric and neonatal outcomes in pregnant women with type 1 diabetes can be reduced with more intense glycaemic control,1 but achieving targets is challenging. Indeed, with specialist input, only 40% of...